TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
9.45
+0.23 (2.49%)
At close: Nov 28, 2025, 1:00 PM EST
9.34
-0.11 (-1.16%)
After-hours: Nov 28, 2025, 4:01 PM EST
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $8.52 million as of November 28, 2025. Its market cap has increased by 27.07% in one year.
Market Cap
8.52M
Enterprise Value
5.68M
1-Year Change
27.07%
Ranking
Category
Stock Price
$9.45
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $8.52M, a decrease of -82.20%. That is a compound annual growth rate of -32.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 8.52M | 263.06% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
| Jul 9, 2021 | 47.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |